Wealth Enhancement Advisory Services’s Upstream Bio UPB Stock Holding History
Bought
Maintained
Sold
Other funds holding UPB
Wealth Enhancement Advisory Services's UPB Position: Q3 2026 in Review
Wealth Enhancement Advisory Services sold out of Upstream Bio (UPB) in Q3 2026, closing a stake of 10,017 shares — an estimated $75.4K sold.
Wealth Enhancement Advisory Services first reported a position in UPB in Q2 2026 and held it in 1 quarter. The position peaked at $75.4K in Q2 2026. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.
- Wealth Enhancement Advisory Services reported no remaining Upstream Bio position as of Q3 2026 after selling out during the quarter.
- Wealth Enhancement Advisory Services sold 10,017 Upstream Bio shares in Q3 2026, an estimated $75.4K.
- Wealth Enhancement Advisory Services first reported a position in Upstream Bio in Q2 2026 and held it in 1 quarter.
- Wealth Enhancement Advisory Services's Upstream Bio position peaked at $75.4K in Q2 2026.
- 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.